Global Saliva Drug and Alcohol Testing Market Growth (Status and Outlook) 2024-2030

Global Saliva Drug and Alcohol Testing Market Growth (Status and Outlook) 2024-2030

Saliva drug and alcohol testing is a method of testing for drugs and alcohol by collecting and analyzing saliva samples. This testing method usually uses a special sampler or test strips to collect a saliva sample from the person being tested. The sampling process is very simple. You only need to place the sampler or test strip in the mouth of the person being tested, let it contact with the saliva for a period of time, and then take out the sampler or test strip. Saliva testing is widely used in a variety of settings, such as the workplace, legal proceedings, sports competitions, etc. It can detect a variety of drugs, including marijuana, cocaine, amphetamines, morphine-based drugs, and the presence of alcohol.

The global Saliva Drug and Alcohol Testing market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

LPI (LP Information)' newest research report, the “Saliva Drug and Alcohol Testing Industry Forecast” looks at past sales and reviews total world Saliva Drug and Alcohol Testing sales in 2023, providing a comprehensive analysis by region and market sector of projected Saliva Drug and Alcohol Testing sales for 2024 through 2030. With Saliva Drug and Alcohol Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Saliva Drug and Alcohol Testing industry.

This Insight Report provides a comprehensive analysis of the global Saliva Drug and Alcohol Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Saliva Drug and Alcohol Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Saliva Drug and Alcohol Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Saliva Drug and Alcohol Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Saliva Drug and Alcohol Testing.

United States market for Saliva Drug and Alcohol Testing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Saliva Drug and Alcohol Testing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Saliva Drug and Alcohol Testing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Saliva Drug and Alcohol Testing players cover Abbott, OraSure Technologies, Premier Biotech, Alcolizer and CareHealth America, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Saliva Drug and Alcohol Testing market by product type, application, key players and key regions and countries.

Segmentation by type
On-Site Screening Products
Lab Testing

Segmentation by application
Criminal Justice Testing
Workplace Testing
Rehabilitation Therapy
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
OraSure Technologies
Premier Biotech
Alcolizer
CareHealth America
AlphaBiolabs
AlcoDigital
VeriCheck
Azova
Draeger
Securetec Detektions-Systeme
Quest Diagnostics
Oranoxis
Salimetrics
Neogen Corporation
UCP Biosciences
Lin-Zhi International
MEDACX
AccuBioTech
Wondfo Biotech
Assure Tech
Express Medicals
Crystal Health
KINNECT
AusHealth
Dorevitch Pathology
Labcorp
Eurofins
Concentra
Bellin Health
Randox
MediNat
Clinical Labs
MHE
Awanui Labs
David Barber Occupational Health
SYNLAB
Test Smartly Labs
Cansford Laboratories
Medigold Health
PAM Group
Drugwise
Safework Health
Humanomics
CannAmm
Micro-Distributing

Please note: The report will take approximately 2 business days to prepare and deliver.